Short Interest in Procaps Group S.A. (NASDAQ:PROC) Expands By 455.1%

Procaps Group S.A. (NASDAQ:PROC) was the target of a significant growth in short interest during the month of November. As of November 15th, there was short interest totalling 113,800 shares, a growth of 455.1% from the October 31st total of 20,500 shares. Based on an average trading volume of 68,700 shares, the short-interest ratio is presently 1.7 days. Currently, 0.6% of the company’s shares are short sold.

Procaps Group Price Performance

Shares of PROC stock traded down $0.58 during trading hours on Friday, reaching $1.51. 105,883 shares of the stock were exchanged, compared to its average volume of 31,129. Procaps Group has a 12-month low of $0.50 and a 12-month high of $4.95. The company’s 50-day moving average price is $1.72 and its 200-day moving average price is $2.13.

Procaps Group Company Profile

Procaps Group SA develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory.